Dr. Tavis Campbell, PhD

The purpose of this project is to design, develop, and test a brief web-based intervention to improve adherence to personal protective behaviours related to COVID-19 prevention among the Canadian general population, with a focus on physical distancing, face masks and vaccination, and to examine the differential effect of this approach among young adults (25 and younger) and males who are at higher risk for non-adherence to protective behaviours. Funding for this project was received by the Canadian Institute of Health Research (CIHR), COVID-19 Research Gaps and Priorities Grant.

The purpose of the Small Changes in PsA study is to develop and test a small-changes behavioral weight loss approach for patients with PsA and obesity. This two-part study consists of a (1) a qualitative investigation to explore barriers and facilitators to behavioural weight loss treatment among patients with PsA and obesity, and (2) a randomized controlled trial to test whether patients who participate in the behavioural weight loss program are more likely to lose weight compared with those who receive treatment as usual from their community rheumatology clinic. This study is being done in collaboration with co-investigators Dr. Michelle Teo and Dr. Lesley Lutes.

This RCT is evaluating the efficacy of intranasal oxytocin versus placebo in improving outcomes among women with chronic pelvic pain. The primary objective is to investigate oxytocin’s efficacy in reducing pain among women with chronic pelvic pain. Secondary objectives include investigating oxytocin’s efficacy in improving emotional function, physical function, and sleep among these women. This study is being done in collaboration with co-investigator Dr. Joshua Rash.

The purpose of the BE-WEL in CR-AF study is to develop and test a small-changes behavioral weight loss approach for patients with atrial fibrillation (AF) and obesity attending a cardiac rehabilitation program. This two-part study consists of a (1) a qualitative investigation to explore barriers and facilitators to behavioural weight loss treatment among patients with AF and obesity, and (2) a randomized controlled trial to test whether patients who receive the behavioural weight loss component during their cardiac rehabilitation program, are more likely to lose 10% of their body weight than those who do cardiac rehab alone. Recruitment for Part I is currently underway.